EBCC 2024 | Very accelerated partial breast irradiation for low-risk breast cancer

Jean-Michel Hannoun-Levi, MD, Antoine Lacassagne Cancer Center, Nice, France, comments on the emerging role of very accelerated partial breast irradiation (VAPBI) in patients with low-risk breast cancer. Administering VAPI in one or two days instead of five proved to be beneficial in patients, with a promising late toxicity profile additionally reported. This interview took place at the 14th European Breast Cancer Conference (EBCC) in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.